| Growth hormone therapy in children; research and practice - A review |
13 |
| IGFBP-4 and PAPP-A in normal physiology and disease |
12 |
| GH and GHR signaling in human disease |
12 |
| Genetic short stature |
9 |
| IGF-1 and cardiovascular disease |
8 |
| Increased postnatal concentrations of pro-inflammatory cytokines are associated with reduced IGF-I levels and retinopathy of prematurity |
7 |
| Depot-specific and GH-dependent regulation of IGF binding protein- pregnancy-associated plasma protein-A, and stanniocalcin-2 in murine adipose tissue |
7 |
| Characterization of an intestine-specific GH receptor knockout (IntGHRKO) mouse |
7 |
| Growth hormone activated STAT5 is required for induction of beige fat in vivo |
6 |
| A useful model to compare human and mouse growth hormone gene chromosomal structure, expression and regulation, and immune tolerance of human growth hormone analogues |
5 |
| The insulin-like growth factor-I receptor stimulating activity (IRSA) in health and disease |
5 |
| Shifting the IGF-axis: An age-related decline in human tear IGF-1 correlates with clinical signs of dry eye |
5 |
| Increased fibrosis: A novel means by which GH influences white adipose tissue function |
5 |
| Analysis of new growth promoting black market products |
5 |
| Value of early postoperative random growth hormone levels and nadir growth hormone levels after oral glucose tolerance testing in acromegaly |
4 |
| IGF research 2016-2018 |
4 |
| Cell-specific expression of insulin/insulin-like growth factor-I receptor hybrids in the mouse brain |
4 |
| Characterization of mouse pericardial fat: regulation by PAPP-A |
4 |
| Pappa2 deletion has sex- and age-specific effects on bone in mice |
3 |
| Long-term adherence adherence to growth hormone therapy in a large health maintenance organization cohort |
3 |
| The insulin-like growth factor family and breast cancer prognosis: A prospective cohort study among postmenopausal women in Denmark |
3 |
| Growth hormone and insulin-like growth factor-I axis in type 1 diabetes |
3 |
| Genetic disorders of GH action pathway |
3 |
| Disruption of the GH receptor gene in adult mice and in insulin sensitive tissues |
3 |
| Active recovery shows favorable IGF-I and IGF binding protein responses following heavy resistance exercise compared to passive recovery |
3 |
| Somatolactogens and diabetic retinopathy |
2 |
| Synergistic effects of tumor necrosis factor-alpha and insulin-like growth factor-I on survival of human trophoblast-derived BeWo cell line |
2 |
| Intermittent hypoxia suppression of growth hormone and insulin-like growth factor-I in the neonatal rat liver |
2 |
| The effect of growth hormone on bioactive IGF in overweight/obese women |
2 |
| Broad variability in pharmacokinetics of GH following rhGH injections in children |
2 |
| Short children born small for gestational age outcomes in the era of growth hormone therapy |
2 |
| Differential expression of IGFBPs in Laron syndrome-derived lymphoblastoid cell lines: Potential correlation with reduced cancer incidence |
2 |
| The IGF-p53 connection in cancer |
2 |
| Challenges and future for the delivery of growth hormone therapy |
2 |
| Treatment of growth failure in the absence of GH signaling: The Ecuadorian experience |
2 |
| Occurrence of neoplasms in individuals with congenital, severe GH deficiency from the Itabaianinha kindred |
2 |
| ALS deficiency caused by an exon 2 deletion and a novel missense variant in the gene encoding ALS |
2 |
| The effect of somatostatin analogues on Ki-67 levels in GH-secreting adenomas |
2 |
| GH responses to whole body vibration alone or in combination with maximal voluntary contractions in obese male adolescents |
2 |
| Growth hormone and Insulin-like growth factor-I (IGF-I) modulate the expression of L-type amino acid transporters in the muscles of spontaneous dwarf rats and L6 and C2C12 myocytes |
2 |
| Thermodynamic analysis of r-hGH-polymer surface Interaction using isothermal titration calorimetry |
2 |
| Efficacy and safety of recombinant human growth hormone in treating Chinese children with idiopathic short stature |
2 |
| Abrogation of GH action in Kupffer cells results in increased hepatic CD36 expression and exaggerated nonalcoholic fatty liver disease |
1 |
| Metabolomics changes in patients with PAPP-A2 deficiency in response to rhIGF1 treatment |
1 |
| A characteristic signature of insulin-like growth factor (IGF) axis expression during osteogenic differentiation of human dental pulp cells (hDPCs): Potential co-ordinated regulation of IGF action |
1 |
| Growth hormone and hematopoiesis: A retrospective analysis on a large cohort of children with growth hormone deficiency |
1 |
| Emotional state, cognitive functioning and quality of life of adult women with Turner syndrome in Lithuania |
1 |
| Soluble delta-like 1 homolog decreases in patients with acromegaly following pituitary surgery: A potential mediator of adipogenesis suppression by growth hormone? |
1 |
| A novel GLI2 mutation responsible for congenital hypopituitarism and polymalformation syndrome |
1 |
| Uniparental disomy and pretreatment IGF-1 may predict elevated IGF-1 levels in Prader-Willi patients on GH treatment |
1 |
